Orbimed Advisors LLC Meira G Tx Holdings PLC Transaction History

Orbimed Advisors LLC

13 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2022 Nov 14, 2022	SELL	$7.55 - $11.25 $2.97 Million - $4.43 Million	-393,475 Reduced 15.73%	2,108,143 $17.7 Million
Q2 2022 Aug 15, 2022	SELL	$6.8 - $14.23 $5.41 Million - $11.3 Million	-795,048 Reduced 24.12%	2,501,618 $18.9 Million
Q1 2022 May 16, 2022	SELL	$13.42 - $23.38 $5.78 Million - $10.1 Million	-430,800 Reduced 11.56%	3,296,666 $45.7 Million
Q4 2021 Feb 14, 2022	SELL	$12.78 - $23.74 $4.8 Million - $8.91 Million	-375,459 Reduced 9.15%	3,727,466 $88.5 Million
Q4 2020 Feb 16, 2021	BUY	$12.4 - $17.6 $4.82 Million - $6.85 Million	389,105 Added 10.48%	4,102,925 $62.1 Million
Q2 2020 Aug 14, 2020	BUY	$11.79 - $15.97 $1.55 Million - $2.1 Million	131,500 Added 3.67%	3,713,820 $46.5 Million
Q1 2020 May 15, 2020	BUY	$9.31 - $21.24 $1.2 Million - $2.75 Million	129,300 Added 3.74%	3,582,320 $48.1 Million
Q4 2019 Feb 14, 2020	BUY	$13.91 - $21.48 $1.45 Million - $2.23 Million	103,960 Added 3.1%	3,453,020 $69.1 Million
Q3 2019 Nov 14, 2019	BUY	$15.84 - $30.01 $12.1 Million - $22.9 Million	762,109 Added 29.46%	3,349,060 $53.4 Million
Q2 2019 Aug 14, 2019	BUY	$17.38 - $26.88 $2.2 Million - $3.41 Million	126,700 Added 5.15%	2,586,951 $69.5 Million
Q1 2019 May 15, 2019	BUY	$9.2 - $21.21 $18.3 Million - $42.2 Million	1,990,298 Added 423.51%	2,460,251 $42.4 Million
Q4 2018 Feb 14, 2019	BUY	$9.61 - $14.02 $2.08 Million - $3.04 Million	216,770 Added 85.62%	469,953 $4.53 Million
Q3 2018 Nov 14, 2018	BUY	$8.1 - $13.6 $2.05 Million - $3.44 Million	253,183 New	253,183 $3.44 Million

100

45.4M

19.2K

31K

Ticker MGTX
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 45,010,700
Market Cap $283M
Description
MeiraGTx Holdings plc, a clinical stage gene therapy company, focusing on developing treatments for patients with serious diseases. The company develops various therapies for ocular diseases, including inherited blindness, as well as Xerostomia following radiation treatment for head and neck cancers; degenerative diseases; neurodegenerative dise...

Get notified when there are updates to the investment portfolio of Orbimed Advisors LLC, based on Form 13F filings with the SEC.

Stay updated on Orbimed Advisors LLC with notifications on news.